Zydus Cadila Desidustat’s better positioned to get first-to-market advantage within HIF-PHI… EP News Bureau Dec 15, 2021 Zydus Cadila has recently filed desidustat in India based on Dream-ND (588 patients) and Dream-D (392 patients) phase-III trials'…